Three years of experience: the Italian registry and safety data updateGianluigi Mancardi, Leandro Provinciali, C. Milanese et al.|Neurological Sciences|2010Cited by 32
Natalizumab therapy of multiple sclerosis: recommendations of the Multiple Sclerosis Study Group—Italian Neurological SocietyG. Tedeschi, Angelo Ghezzi, L. M. E. Grimaldi et al.|Neurological Sciences|2011Cited by 19
The pharmacovigilance program on natalizumab in Italy: 2 years of experienceG. Tedeschi, Gianluigi Mancardi, Maria Pia Amato et al.|Neurological Sciences|2009Cited by 13